Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Sunshine Biopharma (SBFM) Shares Outstanding (Weighted Average) (2016 - 2026)

Sunshine Biopharma filings provide 14 years of Shares Outstanding (Weighted Average) readings, the most recent being $4.2 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 492.39% to $4.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $4.2 million, a 492.39% increase, with the full-year FY2025 number at $4.2 million, up 492.39% from a year prior.
  • Shares Outstanding (Weighted Average) hit $4.2 million in Q4 2025 for Sunshine Biopharma, up from $3.9 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $15.6 million in Q2 2025 to a low of $12675.0 in Q2 2023.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $2.4 million (2021), compared with a mean of $3.9 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): plummeted 99.92% in 2023 and later surged 37991.66% in 2025.
  • Sunshine Biopharma's Shares Outstanding (Weighted Average) stood at $2.6 million in 2021, then skyrocketed by 481.18% to $15.2 million in 2022, then plummeted by 99.92% to $12825.0 in 2023, then surged by 5371.73% to $701749.0 in 2024, then surged by 492.39% to $4.2 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $4.2 million (Q4 2025), $3.9 million (Q3 2025), and $15.6 million (Q2 2025) per Business Quant data.